Capital Fund Management (CFM)’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,348
Closed -$1.35M 2839
2025
Q3
$1.35M Sell
20,348
-29,457
-59% -$1.67M 0.01% 1959
2025
Q2
$2.75M Buy
+49,805
New +$2.39M 0.03% 1508
2025
Q1
Sell
-28,058
Closed -$1.08M 2483
2024
Q4
$1.08M Buy
+28,058
New +$1.22M 0.01% 1730
2023
Q4
Sell
-12,629
Closed -$211K 2486
2023
Q3
$211K Sell
12,629
-13,976
-53% -$271K ﹤0.01% 1899
2023
Q2
$735K Buy
+26,605
New +$666K 0.01% 1492
2022
Q3
Sell
-116,807
Closed -$924K 1762
2022
Q2
$924K Buy
+116,807
New +$1.41M 0.02% 1100

Other funds holding PTGX